{"DataElement":{"publicId":"4566915","version":"1","preferredName":"Disease Response Granulocyte Hyperplasia Assessment Status","preferredDefinition":"The response regarding the state of pathologic and/or clinical changes to the number of granulocyte in an organ resulting in enlargement as a result of treatment.","longName":"DS_RES_GRA_HYP_AS_ST","context":"OHSU Knight","contextVersion":"1","DataElementConcept":{"publicId":"4566911","version":"1","preferredName":"Disease Response Granulocyte Hyperplasia Assessment","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils._An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement._The final result of a determination of the value, significance, or extent of.","longName":"2607696v1.0:4566909v1.0","context":"OHSU Knight","contextVersion":"1","ObjectClass":{"publicId":"2607696","version":"1","preferredName":"Response","preferredDefinition":"In medicine, an improvement related to treatment.","longName":"C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AF31F79-4CA1-08D3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-05","endDate":null,"createdBy":"UMLLOADER_CTOM","dateCreated":"2007-03-05","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4566909","version":"1","preferredName":"Granulocyte Hyperplasia Assessment","preferredDefinition":"A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils.:An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.:The final result of a determination of the value, significance, or extent of.","longName":"C12530:C3113:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulocyte","conceptCode":"C12530","definition":"A type of leukocyte with a multilobed nucleus and cytoplasmic granules. The unique morphology of the nucleus has led to their also being known as polymorphonuclear leukocytes (PMLs or PMNs). Granulocytes are subdivided according to the staining properties of their granules into eosinophils (red with acidic dye), basophils (blue with basic dye), and neutrophils (not amenable to staining with either acidic or basic dyes).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A77FFB-4AC1-40ED-E050-BB89AD4369C8","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"ONEDATA","dateModified":"2014-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A77FFB-4AD2-40ED-E050-BB89AD4369C8","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"10262_OHSU_10.30.14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4566896","version":"1","preferredName":"Disease Response Granulocyte Status","preferredDefinition":"A condition or state at a particular time.","longName":"4566896v1.0","context":"OHSU Knight","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not assessed","valueDescription":"Negation Assessment","ValueMeaning":{"publicId":"3049794","version":"1","preferredName":"Negation Assessment","longName":"3049794","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"836E0020-994D-2647-E040-BB89AD435E03","latestVersionIndicator":"Yes","beginDate":"2010-04-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2010-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06A6B1B6-E889-78BD-E050-BB89AD432ADC","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"ONEDATA","dateModified":"2014-10-30","deletedIndicator":"No"},{"value":"Normal range","valueDescription":"Normal Range","ValueMeaning":{"publicId":"4566897","version":"1","preferredName":"Normal Range","longName":"4566897","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: The difference between the lowest and highest numerical values; the limits or scale of variation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Range","conceptCode":"C38013","definition":"The difference between the lowest and highest numerical values; the limits or scale of variation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A6B1B6-E896-78BD-E050-BB89AD432ADC","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06A6B1B6-E8AF-78BD-E050-BB89AD432ADC","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"ONEDATA","dateModified":"2014-10-30","deletedIndicator":"No"},{"value":"Greater than 50% reduction","valueDescription":"Greater Than Integer::50 Percent Unit Reduced","ValueMeaning":{"publicId":"4566898","version":"1","preferredName":"Greater Than Integer::50 Percent Unit Reduced","longName":"4566898","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::50: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).: Made less in size or amount or degree.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A6B1B6-E8BE-78BD-E050-BB89AD432ADC","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06A6B1B6-E8D7-78BD-E050-BB89AD432ADC","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"ONEDATA","dateModified":"2014-10-30","deletedIndicator":"No"},{"value":"Less than 50% reduction","valueDescription":"Less Than Integer::50 Percent Unit Reduced","ValueMeaning":{"publicId":"4566899","version":"1","preferredName":"Less Than Integer::50 Percent Unit Reduced","longName":"4566899","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::50: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).: Made less in size or amount or degree.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A6B1B6-E8E6-78BD-E050-BB89AD432ADC","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06A6B1B6-E8FF-78BD-E050-BB89AD432ADC","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"ONEDATA","dateModified":"2014-10-30","deletedIndicator":"No"},{"value":"No change","valueDescription":"No Change","ValueMeaning":{"publicId":"3578163","version":"1","preferredName":"No Change","longName":"3578163","preferredDefinition":"The non-affirmative response to a question.: The act of alteration or modification; changed or altered in form or character.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8E2B28C-C1A5-241E-E040-BB89AD4330DA","latestVersionIndicator":"Yes","beginDate":"2012-09-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06A6B1B6-E909-78BD-E050-BB89AD432ADC","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"ONEDATA","dateModified":"2014-10-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A6B1B6-E873-78BD-E050-BB89AD432ADC","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"HARTLEYG","dateModified":"2014-10-30","changeDescription":"10262_OHSU_10.30.14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Granulocyte hyperplasia respo","type":"Preferred Question Text","description":"Granulocyte hyperplasia response:","url":null,"context":"OHSU Knight"},{"name":"OHSU Text 1","type":"Alternate Question Text","description":"Granulocyte hyperplasia response compared to baseline:","url":null,"context":"OHSU Knight"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A7BF5D-9E02-1FCC-E050-BB89AD430E8D","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-30","modifiedBy":"HARTLEYG","dateModified":"2014-10-30","changeDescription":"10262_OHSU_10.30.14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}